AMNEAL PHARMACEUTICALS, INC. AMRX
19.77
(0.04)
(0.20%)
as of 25 Sep
- Market cap
- $6.3B
- P/E
- 39.5×
Follow AMRX
Growth Flags
show if company had growth for consecutive years
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(5.80%) | (79.69%) | (137.24%) | (395.84%) | |
| 0.17% | 2.01% | 3.54% | 4.37% | ||
ROIC |
10.04% | 11.25% | 11.44% | 11.05% | |
Return on Tangible Assets |
0.42% | 4.89% | 8.06% | 10.35% | |
Average Days of Receivables |
110.25 | 108.29 | 102.02 | 119.51 | |
Free Cash Flow per Share |
0.76 | 0.73 | 0.60 | (0.04) | |
Free Cash Flow |
237.88 | 227.73 | 189.67 | (11.59) | |
Capital Expenditures |
(89.87) | (112.26) | (116.17) | (212.37) | |
Piotroski F-Score |
8.00 | 8.00 | 7.00 | 8.00 | |
| Other line items | |||||
Cash ROIC |
12.14% | 12.09% | 10.99% | 7.07% | |
Accounts Receivable Turnover |
3.57 | 3.61 | 3.79 | 3.41 | |
Accounts Payable Turnover |
2.65 | 2.55 | 2.89 | 2.73 | |
Inventory Turnover |
3.07 | 3.13 | 3.01 | 2.94 | |
Average Days of Payables |
143.92 | 145.83 | 129.52 | 139.15 | |
Days of Inventory on Hand |
120.85 | 116.14 | 125.35 | 130.81 | |
Tax Rate |
(0.16) | (0.08) | 0.00 | 0.07 | |
Research and Development Expense of Revenue |
7.01% | 6.17% | 6.06% | 5.63% | |
Selling, General and Administrative Expense of Revenue |
17.34% | 17.45% | 17.97% | 18.34% | |
Share Based Compensation of Revenue |
1.05% | 1.06% | 1.10% | 1.14% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
55.55 | 4.72 | 2.50 | 1.28 | |
Depreciation/Fixed assets |
0.61 | 0.56 | 0.51 | 0.46 | |
Capex/Depreciation |
(0.34) | (0.46) | (0.51) | (1.01) | |
Revenue per Share |
9.34 | 9.63 | 9.64 | 9.77 | |
Operating CF per Share |
1.04 | 1.09 | 0.97 | 0.63 | |
Capex per Share |
(0.29) | (0.36) | (0.37) | (0.67) | |
Capex to Sales |
0.03 | 0.04 | 0.04 | 0.07 | |
Net Profit Margin |
0.20% | 2.39% | 4.01% | 5.05% |
Columns are period end dates